Abstract

A band-aid or ointment on the wound is not always enough, or is it? A healthy 68-year-old man presents with a progressive, ulcerated, livid swelling on the right elbow. After clinicopathological correlation, the diagnosis of a primary cutaneous anaplastic large-cell lymphoma (ALCL) is made. This entity is part of the heterogeneous group of ALCL, which is a subtype of T-cell lymphoma with a similar morphology, but a variable clinical presentation, therapy and prognosis. An ALCL usually occurs in adults, rarely in children and adolescents. Locally or scattered over several sites, large single or multiple slow-growing erythematous papules, nodules or tumours develop. These lesions may ulcerate, exudate and/or itch. Generally, the prognosis is favourable, with a 5-year survival rate of 90%. Spontaneous regression is observed in 25% of the cases. Recurrences are frequent (up to 30% of the cases), but usually remain cutaneous. If technically feasible, a solitary or localized primary cutaneous ALCL can be excised, but if inoperable, radiotherapy is initiated, as in the discussed patient. Case series also describe good responses to a low dose of methotrexate (15-20 mg per week), but recurrences are frequent and the evidence is limited. In case of multifocal skin involvement, combination chemotherapy is used.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call